Search research articles
Contact Us
Filters
Showing results (131-140 of 186) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial
Pasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy
Johan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203
Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
Helen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Clinical Lung Cancer
|
November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress
Heather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Critical Reviews in Oncology/Hematology
|
April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer
Rafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy
Daniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delays
Zachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer
Frank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 186) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial
Pasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy
Johan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203
Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 27, 2015
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer
Helen Chow, Martin J Edelman, Giuiseppe Giaccone, et al.
Clinical Lung Cancer
|
November 11, 2009
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress
Heather Wakelee, Bill W Loo, Kemp H Kernstine, et al.
Critical Reviews in Oncology/Hematology
|
April 24, 2010
A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer
Rafat H Ansari, Mark A Socinski, Martin J Edelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy
Daniel L Adams, Diane K Adams, Jianzhong He, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 7, 2023
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delays
Zachary A K Frosch, Lisa M Jacobs, Caroline S O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 2, 2008
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer
Frank C Detterbeck, Mark A Socinski, Richard J Gralla, et al.
Page
of 19